Status:
UNKNOWN
Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response
Lead Sponsor:
University of Turin, Italy
Collaborating Sponsors:
Research Center Borstel
Conditions:
Tuberculosis, Pulmonary
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to investigate the possible correlation of plasma drug concentrations with Time To Positivity (TTP) in liquid culture in patients with active pulmonary multi sensitive TB in th...
Detailed Description
A longitudinal observational multicentred study will be conducted in patients with diagnosis of active pulmonary TB. The following variables will be recorded: * demographic variables: age, gender, e...
Eligibility Criteria
Inclusion
- signed informed consent
- age \>=18 years;
- pulmonary tuberculosis defined by positive sputum microscopy (waiting for culture confirmation)
- sensitivity to first-line anti-TB drugs;
- normal liver and renal function.
Exclusion
- severe malnutrition;
- HIV infection
Key Trial Info
Start Date :
May 25 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
257 Patients enrolled
Trial Details
Trial ID
NCT03416309
Start Date
May 25 2017
End Date
February 28 2022
Last Update
April 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Amedeo di Savoia
Torino, Italy, 10149